High-resolution melting analysis of the common c.1905+1G>A mutation causing dihydropyrimidine dehydrogenase deficiency and lethal 5-fluorouracil toxicity

Dihydropyrimidine dehydrogenase (DPD) deficiency is a pharmacogenetic syndrome associated with life-threatening toxicity following exposure to the fluoropyrimidine drugs 5-fluorouracil (5-FU) and capecitabine (CAP), widely used for the treatment of colorectal cancer and other solid tumors. The most...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Emma eBorràs, Emma eDotor, Àngels eArcusa, Maria José eGamundi, Imma eHernan, Miguel ede Sousa Dias, Begoña eMañé, José A G Agúndez, Miguel eBlanca, Miguel eCarballo
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2013-01-01
Serier:	Frontiers in Genetics
Fag:	Toxicity 5-fluorouracil capecitabine dihydropyrimidine dehydrogenase DPD DPYD
Online adgang:	http://journal.frontiersin.org/Journal/10.3389/fgene.2012.00312/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!